Gateway Investment Advisers’s Revolution Medicines RVMD Stock Holding History

Gateway Investment Advisers’s Portfolio RVMD Stock Details RVMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$206K	Buy	+1,101	New	+$161K	﹤0.01%	769

Other funds holding RVMD

Handelsbanken Fonder

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Assenagon Asset Management

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return

Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return

a16z Perennial Management Menlo Park, California $1.24B AUM 7.36% 1-Year Est. Return

Wedmont Private Capital West Chester, Pennsylvania $3.65B AUM 26.64% 1-Year Est. Return

IFM Investors Melbourne, Australia $15.1B AUM 40.57% 1-Year Est. Return

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Gateway Investment Advisers's RVMD Position: Q2 2026 in Review

Gateway Investment Advisers opened a new position in Revolution Medicines (RVMD) in Q2 2026: 1,101 shares worth $206K. The stake represents ﹤0.01% of the portfolio and ranks #769 among its holdings.

123 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

Gateway Investment Advisers held 1,101 shares of Revolution Medicines worth $206K as of Q2 2026.
Revolution Medicines was a new Gateway Investment Advisers position in Q2 2026.
Revolution Medicines made up ﹤0.01% of Gateway Investment Advisers's portfolio in Q2 2026, its #769 holding.
123 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Gateway Investment Advisers's 13F filing for Q2 2026, filed 20 Jul 2026.